Company news
Crispr Therapeutics Ag (NASDAQ:CRSP) news
Crispr Therapeutics Ag news releases on 6ix. Latest, Apr 28, 2020: CRISPR Therapeutics Provides Business Update and Reports First Quarter 2020 Financial Results
Press releases — page 4
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2020 Financial Results
April 27, 2020
CRISPR Therapeutics Proposes Changes to the Board of Directors
February 25, 2020
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results
February 11, 2020
CRISPR Therapeutics to Present at the Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View from the Top Conference
January 5, 2020
CRISPR Therapeutics to Present at Upcoming Investor Conferences
November 26, 2019
CRISPR Therapeutics Announces Proposed Public Offering of Common Shares
November 18, 2019
CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data From First Two Patients Treated With Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001® for Severe Hemoglobinopathies
November 18, 2019
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2019 Financial Results
October 27, 2019
CRISPR Therapeutics and KSQ Therapeutics Announce License Agreement to Advance Companies’ Respective Cell Therapy Programs in Oncology
October 14, 2019
CRISPR Therapeutics and ViaCyte Present Positive In Vitro Data Towards a Potential Immune-Evasive Cell Replacement Therapy for Diabetes at EASD 2019
September 16, 2019
CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Beta Thalassemia
April 15, 2019